Status:

COMPLETED

Naturlose (D-Tagatose) Efficacy Evaluation Trial

Lead Sponsor:

Robert Lodder

Collaborating Sponsors:

University of Kentucky

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The purpose of this trial was to evaluate the effectiveness and safety of Naturlose (Tagatose) for glycemic control in people with Type 2 diabetes who were not taking other medications for the conditi...

Detailed Description

This was a Phase 3, prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy, safety, and tolerability of D-tagatose (as compared to placebo). Pri...

Eligibility Criteria

Inclusion

  • Type 2 diabetics in accordance with WHO.
  • Male and female patients, between 18 and 75 years of age.
  • Diabetic patients who are not on medication for the disease. Patients may be treated with diet and exercise.
  • Normal blood creatine clearance and normal liver function test results.
  • BMI less than or equal to 45kg/m2.

Exclusion

  • Treatment with sulfonylurea (e.g., Glyburide, Glipizide, Glimepiride, Chlorpropamide, Tolazamide, Acetohexamide, or Tolbutamide), TZDs, metformin, acarbose, Byetta, insulin, and any antidiabetic medications within the prior 3 months.
  • Therapy with beta-blockers or thiazide diuretics within the prior 3 months.
  • Pregnancy, breastfeeding, or intention of becoming pregnant or judged to be using inadequate contraceptive measure.
  • Documented gastrointestinal disease, or taking of medications likely to alter gut motility or absorption.
  • Receiving any investigational drug within 30 days of the baseline visit.

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

494 Patients enrolled

Trial Details

Trial ID

NCT00955747

Start Date

April 1 2007

End Date

October 1 2010

Last Update

November 19 2014

Active Locations (46)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (46 locations)

1

Simon Williamson Clinc

Hueytown, Alabama, United States, 35023

2

Medical Affiliated Research Center

Huntsville, Alabama, United States, 35801

3

NEA Clinical-Research Solutions

Jonesboro, Arkansas, United States, 72404

4

Alia Clinical Research

Huntington Park, California, United States, 90255